Funder
Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,General Medicine,Biotechnology
Reference50 articles.
1. Altenburg AF, Kreijtz JHCM, de Vries RD, Song F, Fux R, Rimmelzwaan GF, Sutter G, Volz A (2014) Modified Vaccinia Virus Ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases. Viruses-Basel 6:2735–2761.
https://doi.org/10.3390/V6072735
2. Aunins JG (2000) Viral vaccine production in cell culture. In: Spier RE (ed) Encyclopedia of Cell technology. Wiley, New York, pp 1182–1217
3. Boukhebza H, Bellon N, Limacher JM, Inchauspe G (2012) Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines. Hum Vaccin Immunother 8:1746–1757.
https://doi.org/10.4161/hv.21689
4. Brown SW, Mehtali M (2010) The avian EB66® cell line, application to vaccines, and therapeutic protein production. PDA J Pharm Sci Technol 64:419–425
5. Buckland BC (2015) The development and manufacture of influenza vaccines. Hum Vaccin Immunother 11(6):1357–1360.
https://doi.org/10.1080/21645515.2015.1026497
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献